Landos Biopharma Inc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 03/31/24 Q1

ended 12/31/23 FY 2023 – amended

ended 12/31/23 FY 2023

ended 09/30/23 Q3

ended 06/30/23 Q2

Prospectuses and Registrations Filter

Securities registration termination

Removal from listing

Registration withdrawal request

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

Mayleben Timothy M

News Filter

AbbVie Completes Acquisition of Landos Biopharma

Shareholder Vote Results

AbbVie to Acquire Landos Biopharma, Further Strengthening Its Portfolio in Inflammatory and Autoimmune Diseases

Provides Business Update and Reports Fourth Quarter and Full Year 2023 Results

Investor Presentation

Proxies Filter

Proxy related to merger

Preliminary proxy related to merger

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC